3 December 2019

 

Abstract Submission

Deadline for abstract submission: 10 January 2020

The abstract submission platform is open
 

 

Categories for Abstract Submission

01 - From genotype to phenotype
02 - CFTR (i): from structure to function
03 - CFTR (ii): trafficking and interactions
04 - Other channels that modify CFTR containing epithelia
05 - CFTR (iii): Beyond the airway
06 - Inflammation and infection
07 - Mucus and mucins
08 - Current challenges in therapeutics

 

General Instructions

  • Abstracts must be submitted in English.
  • Do not submit abstracts reporting data already published.
  • Abstracts should be as informative as possible and should adequately describe the objectives, methods, and conclusions of the research.
  • All accepted abstracts are to be presented in poster form. A limited number of accepted abstracts will also be selected by the Scientific Committee for oral presentation in the conference sessions. Instructions for poster and oral presentation will be included in the abstract notification to corresponding authors after the review process.
  • Abstracts are to be submitted using the electronic on-line system – no other submission medium may be used. Abstracts sent by fax, post or email will not be accepted.
  • The Travel Grants and support schemes are applicable for all the abstract categories. The Scientific Committee of the Conference will, as part of the abstract review process, select the abstracts they deem most worthy of these awards. For the application form for Travel Grants and Support - see under Travel Grants.

As part of the online submission process, corresponding authors are responsible for:

  • Ensuring that all authors of a submitted abstract agreed to have the abstract submitted and published, if accepted.
  • Acknowledging that the contents of the abstract have not been published prior to the date of submission.
  • Understanding that accepted abstracts will be included in the Final Programme which will be published on the ECFS website.  
 

Other Instructions

  • Abstracts should not contain proprietary or confidential information.
  • The presenting author of an accepted abstract must register for the Conference.